Ciencia de datos e inteligencia artificial en la predicción de eventos cardiovasculares en pacientes hipertensos: una revisión integrativa de la literatura

dc.contributor.advisorSuárez Rojas, Angie Lorena
dc.contributor.authorNúñez Niño, Daniel Enrique
dc.contributor.corporatenameUniversidad Santo Tomás
dc.contributor.cvlachttps://scienti.minciencias.gov.co/cvlac/visualizador/generarCurriculoCv.do?cod_rh=0001829344
dc.date.accessioned2026-07-28T21:24:22Z
dc.date.available2026-07-28T21:24:22Z
dc.date.issued2026-07-10
dc.descriptionLas enfermedades del sistema cardiovascular son la principal causa de mortalidad en el mundo. La hipertensión arterial es el principal factor de riesgo cardiovascular que puede evitarse. En disminuir las muertes por estas enfermedades, el uso de tecnologías innovadoras en esta región es de gran importancia. Este artículo de divulgación se enfatiza en los datos de la región de Tunja, ciudad que ha sido considerado el área de salud en datos, y datos de enfermedades de Tunja, y por tanto, se presentan las previsiones del uso de Ciencia de Datos y de la Inteligencia Artificial en el análisis de la predicción de eventos cardiovasculares en pacientes hipertensos. La revisión de estudios y de la literatura que han sido publicados en bases de datos, y que en la actualidad generan gran impacto en el área de tecnologías de la salud, ha sido sistemática, y los estudios han sido analizados de manera critica, en el uso de herramientas de aprendizaje automático y de las redes neuronales. La aplicación realizada demostró que modelos como Random Forest, XGBoost, y redes neuronales cilíndricas de memoria a largo y corto plazo, presentaron más del 88% de eficiencia en la predicción de infarto agudo de miocardio, en evento v y/o muerte cardiovascular en empresas de hipertensión. La incorporación de herramientas de ciencia de datos en sistemas de salud abiertos proveer conciencia sobre los recursos de prevención y disminución a lo esencial de la medicina.
dc.description.abstractDiseases of the cardiovascular system are the leading cause of mortality in the world. Arterial hypertension is the main cardiovascular risk factor that can be avoided. In reducing deaths from these diseases, the use of innovative technologies in this region is of great importance. This popular article emphasizes the data of the Tunja region, a municipality that has been considered the health area in data, and disease data of Tunja, and therefore, the forecasts of the use of Data Science and Artificial Intelligence in the analysis of the prediction of cardiovascular events in hypertensive patients are presented. The review of studies and literature that have been published in databases, and that currently generate great impact in the area of health technologies, has been systematic, and the studies have been critically analyzed, in the use of machine learning tools and neural networks. The application showed that models such as Random Forest, XGBoost, and cylindrical neural networks of long-term and short-term memory, presented more than 88% efficiency in the prediction of acute myocardial infarction, event v and/or cardiovascular death in hypertension companies. The incorporation of data science tools in open health systems provide awareness about prevention resources and reduce the essentials of medicine.
dc.description.degreelevelPregradospa
dc.description.degreenameIngeniero Informáticospa
dc.description.domainhttp://www.ustatunja.edu.co/investigacion
dc.format.mimetypeapplication/pdf
dc.identifier.citationNuñez Niño, D. E. (2026). Ciencia de datos e inteligencia artificial en la predicción de eventos cardiovasculares en pacientes hipertensos: una revisión integrativa de la literatura [Trabajo de Grado, Universidad Santo Tomás].Repositorio Institucional
dc.identifier.instnameinstname:Universidad Santo Tomásspa
dc.identifier.reponamereponame:Repositorio Institucional Universidad Santo Tomásspa
dc.identifier.repourlrepourl:https://repository.usta.edu.cospa
dc.identifier.urihttp://hdl.handle.net/11634/73610
dc.language.isospa
dc.publisherUniversidad Santo Tomásspa
dc.publisher.branchCRAI-USTA Tunja
dc.publisher.facultyFacultad de Ingeniería de Sistemasspa
dc.publisher.programIngeniería Informáticaspa
dc.relation.referencesWorld Health Organization. (2023). Cardiovascular diseases (CVDs) - Fact sheet. WHO Press. https://www.who.int/news-room/fact-sheets/detail/cardiovasculardiseases
dc.relation.referencesRoth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., ... & Fuster, V. (2020). Global burden of cardiovascular diseases and risk factors, 1990–2019. Journal of the American College of Cardiology, 76(25), 2982– 3021. https://doi.org/10.1016/j.jacc.2020.11.010
dc.relation.referencesMills, K. T., Stefanescu, A., & He, J. (2020). The global epidemiology of hypertension. Nature Reviews Nephrology, 16(4), 223–237. https://doi.org/10.1038/s41581-019-0244-2
dc.relation.referencesOrdunez, P., Prieto-Lara, E., Gawryszewski, V., Hennis, A. J., & Cooper, R. S. (2016). Premature mortality from cardiovascular disease in the Americas. PLOS ONE, 11(3), e0151441. https://doi.org/10.1371/journal.pone.0151441
dc.relation.referencesMinisterio de Salud y Protección Social de Colombia. (2022). Análisis de situación de salud (ASIS) Colombia 2022. Ministerio de Salud. https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/ED/PSP/asi s-colombia-2022.pdf
dc.relation.referencesSecretaría de Salud de Boyacá. (2023). Informe de situación de salud del departamento de Boyacá 2023. Gobernación de Boyacá
dc.relation.referencesAmbale-Venkatesh, B., Yang, X., Wu, C. O., Liu, K., Hundley, W. G., McClelland, R., ... & Lima, J. A. (2017). Cardiovascular event prediction by machine learning. Circulation Research, 121(9), 1092–1101. https://doi.org/10.1161/CIRCRESAHA.117.311312
dc.relation.referencesWeng, S. F., Reps, J., Kai, J., Garibaldi, J. M., & Qureshi, N. (2017). Can machinelearning improve cardiovascular risk prediction using routine clinical data? PLOS ONE, 12(4), e0174944. https://doi.org/10.1371/journal.pone.0174944
dc.relation.referencesHerrera-Gómez, F., & González-Ruiz, S. L. (2021). Inteligencia artificial en salud cardiovascular en Colombia: revisión sistemática. Revista Colombiana de Cardiología, 28(3), 201–214. https://doi.org/10.1016/j.rccar.2020.09.012
dc.relation.referencesMoher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLOS Medicine, 6(7), e1000097. https://doi.org/10.1371/journal.pmed.1000097
dc.relation.referencesStroup, D. F., Berlin, J. A., Morton, S. C., Olkin, I., Williamson, G. D., Rennie, D., ... & Thacker, S. B. (2000). Meta-analysis of observational studies in epidemiology. JAMA, 283(15), 2008–2012. https://doi.org/10.1001/jama.283.15.200
dc.relation.referencesLiberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P., ... & Moher, D. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions. Annals of Internal Medicine, 151(4), W65–W94.
dc.relation.referencesPage, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., ... & Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. The BMJ, 372, n71. https://doi.org/10.1136/bmj.n71
dc.relation.referencesWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., ... & Wright, J. T. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Journal of the American College of Cardiology, 71(19), e127–e248
dc.relation.referencesWilliams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., ... & Desormais, I. (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal, 39(33), 3021–3104. https://doi.org/10.1093/eurheartj/ehy339
dc.relation.referencesOparil, S., Acelajado, M. C., Bakris, G. L., Berlowitz, D. R., Cífková, R., Dominiczak, A. F., ... & Whelton, P. K. (2018). Hypertension. Nature Reviews Disease Primers, 4, 18014. https://doi.org/10.1038/nrdp.2018.14
dc.relation.referencesKrause, J., Perer, A., & Ng, K. (2016). Interacting with predictions: visual inspection of black-box machine learning models. In Proceedings of the 2016 CHI conference on human factors in computing systems (pp. 5686–5697).
dc.relation.referencesBöhm, M., Schumacher, H., Teo, K. K., Lonn, E. M., Mahfoud, F., Mann, J. F., ... & Yusuf, S. (2019). Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120–140 mmHg) and cardiovascular outcomes in highrisk patients: results from ONTARGET and TRANSCEND trials. European Heart Journal, 40(34), 2870–2882.
dc.relation.referencesEttehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., ... & Rahimi, K. (2016). Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. The Lancet, 387(10022), 957–967.
dc.relation.referencesPichon-Riviere, A., Irazola, V., Beratarrechea, A., Alcaraz, A., & Carrara, C. (2013). Quality of life in hypertensive patients and economical impact of uncontrolled hypertension in eight Latin American countries. Revista Panamericana de Salud Pública, 33(6), 395–402.
dc.relation.referencesMeylan-Cartier, N., & Ruidíaz-Gomez, K. (2020). Cardiovascular risk and altitude: epidemiology and clinical considerations in the Colombian Andes. Archivos de Medicina, 20(1), 215–228.
dc.relation.referencesObermeyer, Z., & Emanuel, E. J. (2016). Predicting the future — big data, machine learning, and clinical medicine. New England Journal of Medicine, 375(13), 1216–1219. https://doi.org/10.1056/NEJMp1606181
dc.relation.referencesDeo, R. C. (2015). Machine learning in medicine. Circulation, 132(20), 1920– 1930. https://doi.org/10.1161/CIRCULATIONAHA.115.001593
dc.relation.referencesTopol, E. J. (2019). High-performance medicine: the convergence of human and artificial intelligence. Nature Medicine, 25(1), 44–56. https://doi.org/10.1038/s41591-018-0300-7
dc.relation.referencesWilson, P. W., D'Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998). Prediction of coronary heart disease using risk factor categories. Circulation, 97(18), 1837–1847.
dc.relation.referencesGoff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D'agostino, R. B., Gibbons, R., ... & Zhao, Y. (2014). 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 129(25 Suppl 2), S49– S73.
dc.relation.referencesKakadiaris, I. A., Vrigkas, M., Yen, A. A., Kuznetsova, T., Budoff, M., & Naghavi, M. (2018). Machine learning outperforms ACC/AHA CVD risk calculator in MESA. Journal of the American Heart Association, 7(22), e009476.
dc.relation.referencesMotwani, M., Dey, D., Berman, D. S., Germano, G., Achenbach, S., Al- Mallah, M. H., ... & Slomka, P. J. (2017). Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease. European Heart Journal, 38(7), 500–507.
dc.relation.referencesAlaa, A. M., Bolton, T., Di Angelantonio, E., Rudd, J. H., & van der Schaar, M. (2019). Cardiovascular disease risk prediction using automated machine learning: a prospective study of 423,604 UK Biobank participants. PLOS ONE, 14(5), e0213653. https://doi.org/10.1371/journal.pone.0213653
dc.relation.referencesChen, T., & Guestrin, C. (2016). XGBoost: A scalable tree boosting system. In Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining (pp. 785–794). https://doi.org/10.1145/2939672.2939785
dc.relation.referencesDimopoulos, A. C., Nikolaidou, M., Caballero, F. F., Engchuan, W., Sanchez- Niubo, A., Arndt, H., ... & Panagiotakos, D. B. (2018). Machine learning methodologies versus cardiovascular risk scores, in predicting disease risk. BMC Medical Research Methodology, 18(1), 1–11.
dc.relation.referencesHochreiter, S., & Schmidhuber, J. (1997). Long short-term memory. Neural Computation, 9(8), 1735–1780.
dc.relation.referencesRajpurkar, P., Hannun, A. Y., Haghpanahi, M., Bourn, C., & Ng, A. Y. (2017). Cardiologist-level arrhythmia detection with convolutional neural networks. arXiv preprint arXiv:1707.01836.
dc.relation.referencesLee, J., Yoon, W., Kim, S., Kim, D., Kim, S., So, C. H., & Kang, J. (2020). BioBERT: a pre-trained biomedical language representation model for biomedical text mining. Bioinformatics, 36(4), 1234–1240. https://doi.org/10.1093/bioinformatics/btz682
dc.relation.referencesLundberg, S. M., & Lee, S. I. (2017). A unified approach to interpreting model predictions. In Advances in neural information processing systems (Vol. 30, pp. 4765–4774).
dc.relation.referencesPencina, M. J., D'Agostino, R. B., Larson, M. G., Massaro, J. M., & Vasan, R. S. (2009). Predicting the 30-year risk of cardiovascular disease: the Framingham Heart Study. Circulation, 119(24), 3078–3084.
dc.relation.referencesKrittanawong, C., Johnson, K. W., Rosenson, R. S., Wang, Z., Aydar, M., Baber, U., ... & Bhatt, D. L. (2020). Deep learning for cardiovascular medicine: a practical primer. European Heart Journal, 40(25), 2058–2073.
dc.relation.referencesRamspek, C. L., Jager, K. J., Dekker, F. W., Zoccali, C., & van Diepen, M. (2021). External validation of prognostic models: what, why, how, when and where? Clinical Kidney Journal, 14(1), 49–58.
dc.relation.referencesBaena-Díez, J. M., Peñafiel, J., Subirana, I., Ramos, R., Elosua, R., Marín- Ibañez, A., ... & Marrugat, J. (2016). Risk of cause-specific death in individuals with cardiovascular disease. Journal of the American College of Cardiology, 68(3), 240– 250.
dc.relation.referencesIrazola, V. E., Gutierrez, L., Bloomfield, G., Carrillo-Larco, R. M., Dorantes- Alonso, A., Figueroa, R., ... & Rubinstein, A. (2016). Hypertension prevalence, awareness, treatment, and control in selected LMIC communities. Global Heart, 11(1), 47–59.
dc.relation.referencesPopejoy, A. B., & Fullerton, S. M. (2016). Genomics is failing on diversity. Nature, 538(7624), 161–164. https://doi.org/10.1038/538161a
dc.relation.referencesRajkomar, A., Hardt, M., Howell, M. D., Corrado, G., & Chin, M. H. (2018). Ensuring fairness in machine learning to advance health equity. Annals of Internal Medicine, 169(12), 866–872.
dc.relation.referencesNavarro, M., Ospina, J., & Torres, C. (2022). Modelo predictivo de infarto agudo de miocardio en pacientes hipertensos colombianos mediante gradient boosting. Revista Colombiana de Cardiología, 29(4), 312–321.
dc.relation.referencesPosada-Moreno, P., López-Jaramillo, P., & Velásquez-Vélez, D. (2023). Comparación de modelos estadísticos e inteligencia artificial para la predicción de ACV en hipertensos de Medellín. Biomédica, 43(2), 198–213.
dc.relation.referencesUniversidad Santo Tomás Tunja. (2023). Plan de desarrollo institucional 2023-2027: Investigación e innovación en sistemas de información en salud. USTA.
dc.relation.referencesCook, N. R. (2007). Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation, 115(7), 928–935.
dc.relation.referencesKaviani, A., Nader, S., Park, H., & Jameson, H. A. (2022). Artificial intelligence and machine learning for predicting cardiovascular disease events. Current Cardiology Reports, 24(11), 1503–1511.
dc.relation.referencesConroy, R. M., Pyörälä, K., Fitzgerald, A. P., Sans, S., Menotti, A., De Backer, G., ... & Graham, I. M. (2003). Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. European Heart Journal, 24(11), 987–1003.
dc.relation.referencesRudin, C. (2019). Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead. Nature Machine Intelligence, 1(5), 206–215. https://doi.org/10.1038/s42256-019-0048-x
dc.relation.referencesArrieta, A. B., Díaz-Rodríguez, N., Del Ser, J., Bennetot, A., Tabik, S., Barbado, A., ... & Herrera, F. (2020). Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI. Information Fusion, 58, 82–115.
dc.relation.referencesObermeyer, Z., Powers, B., Vogeli, C., & Mullainathan, S. (2019). Dissecting racial bias in an algorithm used to manage the health of populations. Science, 366(6464), 447–453. https://doi.org/10.1126/science.aax2342
dc.relation.referencesLópez-Jaramillo, P., Sánchez, R. A., Díaz, M., Cobos, L., Bryce, A., Parra- Carrillo, J. Z., ... & López-López, J. (2013). Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome. Journal of Hypertension, 31(2), 223–238.
dc.relation.referencesFloridi, L., Cowls, J., Beltrametti, M., Chatila, R., Chazerand, P., Dignum, V., ... & Vayena, E. (2018). An ethical framework for a good AI society: Opportunities, risks, principles, and recommendations. Minds and Machines, 28(4), 689–707.
dc.relation.referencesMinisterio de Salud y Protección Social de Colombia. (2019). Resolución 2654 de 2019: Telemedicina y habilitación de servicios de salud a distancia. Ministerio de Salud.
dc.rightsAttribution-NonCommercial-NoDerivs 2.5 Colombiaen
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2
dc.rights.localAbierto (Texto Completo)spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.subject.keywordArterial hypertension
dc.subject.keywordData science
dc.subject.keywordArtificial intelligence
dc.subject.keywordCardiovascular prediction
dc.subject.keywordMachine learning
dc.subject.keywordCardiovascular events
dc.subject.keywordPublic health
dc.subject.proposalHipertensión arterial
dc.subject.proposalCiencia de datos
dc.subject.proposalInteligencia artificial
dc.subject.proposalPredicción cardiovascular
dc.subject.proposalAprendizaje automático
dc.subject.proposalEventos cardiovasculares
dc.subject.proposalSalud pública
dc.titleCiencia de datos e inteligencia artificial en la predicción de eventos cardiovasculares en pacientes hipertensos: una revisión integrativa de la literatura
dc.typebachelor thesis
dc.type.coarhttp://purl.org/coar/resource_type/c_7a1f
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aa
dc.type.driveinfo:eu-repo/semantics/bachelorThesis
dc.type.localTrabajo de gradospa
dc.type.versioninfo:eu-repo/semantics/acceptedVersion

Archivos

Bloque original

Mostrando 1 - 3 de 3
Cargando...
Miniatura
Nombre:
2026DanielNuñez
Tamaño:
2.55 MB
Formato:
Adobe Portable Document Format
Cargando...
Miniatura
Nombre:
Autorización facultad
Tamaño:
402.32 KB
Formato:
Adobe Portable Document Format
Cargando...
Miniatura
Nombre:
Autorización estudiante
Tamaño:
328.9 KB
Formato:
Adobe Portable Document Format

Bloque de licencias

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
license.txt
Tamaño:
807 B
Formato:
Item-specific license agreed upon to submission
Descripción: